Research Article
No access
Published Online: 15 January 2014

Carbon Monoxide Confers Protection in Sepsis by Enhancing Beclin 1-Dependent Autophagy and Phagocytosis

Publication: Antioxidants & Redox Signaling
Volume 20, Issue Number 3

Abstract

Aims: Sepsis, a systemic inflammatory response to infection, represents the leading cause of death in critically ill patients. However, the pathogenesis of sepsis remains incompletely understood. Carbon monoxide (CO), when administered at low physiologic doses, can modulate cell proliferation, apoptosis, and inflammation in pre-clinical tissue injury models, though its mechanism of action in sepsis remains unclear. Results: CO (250 ppm) inhalation increased the survival of C57BL/6J mice injured by cecal ligation and puncture (CLP) through the induction of autophagy, the down-regulation of pro-inflammatory cytokines, and by decreasing the levels of bacteria in blood and vital organs, such as the lung and liver. Mice deficient in the autophagic protein, Beclin 1 (Becn1+/−) were more susceptible to CLP-induced sepsis, and unresponsive to CO therapy, relative to their corresponding wild-type (Becn1+/+) littermate mice. In contrast, mice deficient in autophagic protein microtubule-associated protein-1 light chain 3B (LC3B) (Map1lc3b−/−) and their corresponding wild-type (Map1lc3b+/+) mice showed no differences in survival or response to CO, during CLP-induced sepsis. CO enhanced bacterial phagocytosis in Becn1+/+ but not Becn1+/− mice in vivo and in corresponding cultured macrophages. CO also enhanced Beclin 1-dependent induction of macrophage protein signaling lymphocyte-activation molecule, a regulator of phagocytosis. Innovation: Our findings demonstrate a novel protective effect of CO in sepsis, dependent on autophagy protein Beclin 1, in a murine model of CLP-induced polymicrobial sepsis. Conclusion: CO increases the survival of mice injured by CLP through systemic enhancement of autophagy and phagocytosis. Taken together, we suggest that CO gas may represent a novel therapy for patients with sepsis. Antioxid. Redox Signal. 20, 432–442.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Aita VM, Liang XH, Murty VV, Princus DL, Yu W, Cayanis E, Kalachikov S, Gilliam TC, and Lecine B. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59: 59–65, 1999.
2.
Anaya DA and Nathens AB. Risk factors for severe sepsis in secondary peritonitis. Surg Infect (Larchmt) 4: 355–362, 2003.
3.
Berger SB, Romero X, Ma C, Wang G, Faubion WA, Liao G, Compeer E, Keszei M, Rameh L, Wang N, Boes M, Regueiro JR, Reinecher HC, and Terhorst C. SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages. Nat Immunol 11: 920–927, 2010.
4.
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, and Fisher CJ. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699–709, 2001.
5.
Bone RC, Grodzin CJ, and Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112: 235–243, 1997.
6.
Carchman EH, Rao J, Loughran PA, Rosengart MR, and Zuckerbraun BS. Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice. Hepatology 53: 2053–2062, 2011.
7.
Chen ZH, Kin HP, Sciurba FC, Lee SJ, Feghali-Bostwick C, Stolz DB, Dhir R, Landreneau RJ, Schuchert MJ, Yousem SA, Nakahira K, Ryter SW, Morita K, and Choi AM. Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One 3: e3313, 2008.
8.
Chhikara M, Wang S, Kern SJ, Ferreyra GA, Barb JJ, Munson PJ, and Danner RL. Carbon monoxide blocks lipopolysaccharide-induced gene expression by interfering with proximal TLR4 to NF-κB signal transduction in human monocytes. PLoS One 12: e8139, 2009.
9.
Chiang N, Shinohara M, Dalli J, Mirakaj V, Kibi M, Choi AMK, and Serhan CN. Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits. J Immunol 190: 6378–6388, 2013.
10.
Chung SW, Liu X, Macias AA, Baron RM, and Perrella MA. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest 118: 239–247, 2008.
11.
Crotzer VL and Blum JS. Autophagy and its role on MHC-mediated antigen presentation. J Immunol 182: 3335–3341, 2009.
12.
Ding Y, Kim JK, Kim SI, Na HJ, Jun SY, Lee SJ, and Choi ME. TGF-{beta}-1 protects against mesangial cell apoptosis via induction of autophagy. J Biol Chem 285: 37909–37919, 2010.
13.
Dolinay T, Szilasi M, Liu M, and Choi AM. Inhaled carbon monoxide confers anti-inflammatory effects against ventilator-induced lung injury. Am J Respir Crit Care Med 170: 613–620, 2004.
14.
Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, and Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery if IL-1β. EMBO J 30: 4701–4711, 2011.
15.
Fredenburgh LE, Suárez Velandia MM, Ma J, Olszak T, Cernadas M, Englert JA, Chung SW, Liu X, Begay C, Padera RF, Blumberg RS, Walsh SR, Baron RM, and Perrella MA. Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis. J Immunol 187: 5255–5267, 2011.
16.
He C and Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43: 67–93, 2009.
17.
Hoetzel A, Dolinay T, Schmidt R, Choi AM, and Ryter SW. Carbon monoxide in sepsis. Antioxid Redox Signal 9: 2013–2026, 2007.
18.
Hoetzel A, Vagts DA, Loop T, Humar M, Bauer M, Pahl HL, Geiger KK, and Pannen BJ. Effect of nitric oxide on shock-induced hepatic heme oxygenase-1 expression in the rat. Hepatology 33: 925–937, 2001.
19.
Hotchkiss RS and Karl IE. The pathology and treatment of sepsis. N Engl J Med 348: 138–150, 2003.
20.
Keyse SM and Tyrrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA 86: 99–103, 1989.
21.
Kim HP, Ryter SW, and Choi AM. CO as a cellular signaling molecule. Annu Rev Phamacol Toxicol 46: 411–449, 2006.
22.
Kim HP, Wang X, Nakao A, Kim SI, Murase N, Choi ME, Ryter SW, and Choi AM. Caveolin-1 expression by mean of p38beta mitogen activated protein kinase mediates the antiptoliferative effect of carbon monoxide. Proc Natl Acad Sci USA 102: 11319–11324, 2005.
23.
Lee SJ, Kim HP, Jin Y, Choi AM, and Ryter SW. Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis. Autophagy 7: 829–839, 2011.
24.
Lee SJ, Ryter SW, Xu JF, Nakahira K, Kim HP, Choi AM, and Kim YS. Carbon monoxide activates autophagy via mitochondrial reactive oxygen species formation. Am J Respir Cell Mol Biol 45: 867–873, 2011.
25.
Levine B and Kroemer G. Autophagy in the pathogenesis of disease. Cell 132: 27–42, 2008
26.
Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672–676, 1999.
27.
Martinez J, Almendinger J, Oberst A, Ness R, Dillon CP, Fitzgerald P, Hengartner MO, and Green DR. Microtubule-associated protein 1 light chain 3 alpha (LC3B)-associated phagocytosis is required for the efficient clearance of death cells. Proc Natl Acad Sci USA 108: 17306–17401, 2011
28.
Mizushima N and Komatsu M. Autophagy: renovation of cells and tissues. Cell 147: 728–741, 2011.
29.
Nakahira K, Haspel JA, Rathinam VK, Lee SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, Fitzgerald KA, Ryter SW, and Choi AM. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP inflammasome. Nat Immunol 3: 222–230, 2011.
30.
Otterbein LE, Bach FH, Alam J, Soares M, Tao LH, Wysk M, Davis RJ, Flavell RA, and Choi AM. Carbon monoxide has anti inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422–428, 2000.
31.
Otterbein LE, Mantell LL, and Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 276: L688–L694, 1999.
32.
Otterbein LE, May A, and Chin BY. Carbon monoxide increases macrophagy bacterial clearance through Toll-like receptor (TLR) 4 expression. Cell Mol Biol (Noisy-le-grand) 51: 433–440, 2005.
33.
Pinsky MR. Sepsis: a pro- and anti- inflammatory disequilibrium syndrome. Conrib Nephrol 132: 354–366, 2001.
34.
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, and Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368–1377, 2001.
35.
Ryter SW, Alam J, and Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583–650, 2006.
36.
Saitoh T, Fujima N, Jang MH, Uematsu S, Yang BG, Satoh T, Omori H, Noda T, Yamamoto N, Komatsu M, Tanaka K, Kawai T, Tsujimura T, Takeuchi O, Yoshimori T, and Akira S. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production. Nature 456: 264–268, 2008.
37.
Sammut IA, Foresti R, Clark JE, Exon DJ, Vesely MJ, Sarathchandra P, Green CJ, and Motterlini R. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high level of hemeoxygenase-1. Br J Phamacol 7: 1437–1444, 1998.
38.
Sanjuan MA, Dillon CP, Tait SWG, Moshiach S, Dorsey F, Connell S, Komatsu M, Tanaka K, Cleveland JL, Withoff S, and Green DR. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450: 1253–1257, 2007.
39.
Tenhunen R, Marver HS, and Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 61: 748–755, 1968.
40.
Underhill DM and Goodridge HS. Information processing during phagocytosis. Nat Rev Immunol 12: 492–502, 2012.
41.
Vernon PJ and Tang D. Eat-me: autophagy, phagocytosis, and reactive oxygen species signaling. Antioxid Redox Signal 6: 677–691, 2013.
42.
Virgin HW and Levine B, Autophagy genes in immunity. Nat Immunol 10: 461–470, 2009.
43.
Wang X, Wang Y, Kim HP, Nakahira K, Ryter SW, and Choi AM. Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J Biol Chem 282: 1718–1726, 2007.
44.
Wang X, Zhou Y, Kim HP, Song R, Zarnegar R, Ryter SW, and Choi AM. Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells. J Biol Chem 279: 5237–5243, 2004.
45.
Watson RO, Manzanillo PS, and Cox JS. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 150: 803–805, 2012.
46.
Wegiel B, Gallo DJ, Raman KG, Karlsson JH, Ozanich B, Chin BY, Tzeng E, Admad S, Ahmed A, Baty CJ, and Otterbein LE. Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation 121: 537–548, 2010.
47.
Wegiel B, Hanto DW, and Otterbein LE. The social network of carbon monoxide in medicine. Trends Mol Med 19: 3–11, 2013.
48.
Yue Z, Horton A, Bravin M, DeJager PL, Selimi F, and Heintz N. A novel protein complex linking the delta 2 glutamate receptor and autophagy: implications for neurodegeneration in lurcher mice. Neuron 35: 921–933, 2002.
49.
Yue Z, Jin S, Yang C, Levine AJ, and Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 100: 15077–15082, 2003.
50.
Zhang X, Shan P, Otterbein LE, Alam J, Flavell RA, Davis RJ, Choi AM, and Lee PJ. Carbon monoxide inhibition of apoptotic during ischemia-reperfusion injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase-3. J Biol Chem 278: 1248–1258, 2003.

Information & Authors

Information

Published In

cover image Antioxidants & Redox Signaling
Antioxidants & Redox Signaling
Volume 20Issue Number 3January 20, 2014
Pages: 432 - 442
PubMed: 23971531

History

Published in print: January 20, 2014
Published online: 15 January 2014
Published ahead of print: 5 October 2013
Published ahead of production: 25 August 2013
Accepted: 23 August 2013
Revision received: 5 August 2013
Received: 14 April 2013

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Seonmin Lee
*
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Seon-Jin Lee*
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Biomedical Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Anna A. Coronata
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Laura E. Fredenburgh
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Su Wol Chung
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Biological Sciences, College of Natural Sciences, University of Ulsan, Ulsan, South Korea.
Mark A. Perrella
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Kiichi Nakahira
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Stefan W. Ryter
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Augustine M.K. Choi
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Notes

Address correspondence to:Dr. Augustine M.K. ChoiChairman, Department of MedicineThe E. Hugh Luckey Distinguished Professor of MedicineWeill Cornell Medical CollegePhysician-in-Chief, New York-Presbyterian HospitalWeill Cornell Medical Center525 East 68th StreetRoom M-522, Box 130New York, NY 10065E-mail: [email protected]

Author Disclosure Statement

No competing financial interests exist.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Figures

Tables

Media

Share

Share

Copy the content Link

Share on social media

Back to Top